companydata.dkcompanydata.dk

Ebumab Holding ApS: Financial statements 2020

CVR: 39807556

Source: annual report 2020, Danish Business Authority

01/01/2020 – 31/12/2020

Ebumab Holding ApS (CVR 39807556) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 785,388 and a net result of DKK -337,322. The profit margin was -42.9%. Equity in the 2020 report amounted to DKK 5,209,717. The solvency ratio was 47.8%. The company had 1 employee in the financial year.

Revenue
DKK 785,388
Gross Profit
DKK 392,099
Profit/Loss
DKK -337,322
Equity
DKK 5,209,717
Total Assets
DKK 10,891,452
Employees
1

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Ebumab Holding ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Batchelor Holding ApS registered as owner of Ebumab Holding ApSDec 14, 2020

As of December 14, 2020, Batchelor Holding ApS is registered as an owner of Ebumab Holding ApS with an ownership share of 10%.

Mabe Invest ApS registered as owner of Ebumab Holding ApSDec 14, 2020

As of December 14, 2020, Mabe Invest ApS is registered as an owner of Ebumab Holding ApS with an ownership share of 5%.

Johan H. Faber ApS registered as owner of Ebumab Holding ApSNov 25, 2020

As of November 25, 2020, Johan H. Faber ApS is registered as an owner of Ebumab Holding ApS with an ownership share of 50%.

Ebumab Holding ApS publishes interim reportAug 14, 2020

Ebumab Holding ApS has published its interim report for the period August 24, 2018 to December 31, 2019.

Ebumab Holding ApS appoints new auditorJul 15, 2020

As of July 15, 2020, Slotsgade Revision ApS has been appointed auditor of Ebumab Holding ApS.

Auditor steps down at Ebumab Holding ApSJul 15, 2020

As of July 15, 2020, KAPPELSKOV REVISION. GODKENDT REVISIONSAKTIESELSKAB has stepped down as auditor of Ebumab Holding ApS.

Hans Heugh Wandall joins the board of Ebumab Holding ApSJun 22, 2020

As of June 22, 2020, Hans Heugh Wandall has joined the board of directors of Ebumab Holding ApS.

Søren Erik Bjørn joins the board of Ebumab Holding ApSJun 22, 2020

As of June 22, 2020, Søren Erik Bjørn has joined the board of directors of Ebumab Holding ApS.

Kim Stengaard Holmsted leaves the board of Ebumab Holding ApSJun 22, 2020

As of June 22, 2020, Kim Stengaard Holmsted has left the board of directors of Ebumab Holding ApS.

Wandall Holding ApS registered as owner of Ebumab Holding ApSJun 22, 2020

As of June 22, 2020, Wandall Holding ApS is registered as an owner of Ebumab Holding ApS with an ownership share of 15%.

About Ebumab Holding ApS

Ebumab Holding ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2018. The company is registered under the industry Ikke-finansielle hovedsæders aktiviteter. The management consists of Hans Heugh Wandall and Johan Henrik Faber. The board consists of Hans Heugh Wandall (chair), Johan Henrik Faber, Mads Nikolaj Behrndt-Eriksen and Søren Erik Bjørn. The company's owners include Wandall Holding ApS, Johan H. Faber ApS and Batchelor Holding ApS. The company has 1 employee (2024). In 2025, the company reported a gross profit of DKK -86,871 and a net result of DKK 75,634,949 compared with DKK -39,197 the year before. Equity in the 2025 report amounted to DKK 5,684,083.

Source: annual report 2025, Danish Business Authority

Other financial years